У нас вы можете посмотреть бесплатно Ranking of Scientific Articles in Cardiology and Cardiovascular Medicine 1996 2024 или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
This comprehensive longitudinal study provides a rigorous and systematic ranking of the most influential scholarly publications in Cardiology and Cardiovascular Medicine, spanning a pivotal 28-year trajectory from 1996 to 2024. As the leading cause of global mortality, cardiovascular diseases have been the focus of intense research, leading to transformative shifts from invasive surgical procedures to Interventional Cardiology, Advanced Pharmacotherapy, and Electrophysiology. This ranking identifies the seminal research that has redefined clinical guidelines and drastically improved patient survival rates worldwide. The evaluation framework utilizes sophisticated bibliometric indicators, including field-weighted citation impact (FWCI), h-index metrics, and the prestige of premier journals such as The Lancet, Journal of the American College of Cardiology (JACC), Circulation, and European Heart Journal. The analysis provides a comprehensive map of the intellectual milestones across four core domains: Ischemic Heart Disease & Interventions: Highlighting breakthroughs in drug-eluting stents (DES), antiplatelet therapy, and the evolution of percutaneous coronary intervention (PCI) techniques. Heart Failure & Regenerative Medicine: Analyzing the impact of research into neurohormonal blockade, ventricular assist devices (VADs), and emerging cellular therapies. Cardiac Arrhythmias & Electrophysiology: Tracking the development of catheter ablation, implantable cardioverter-defibrillators (ICDs), and the management of atrial fibrillation. Preventive Cardiology & Epidemiology: Evaluating high-impact studies on lipid-lowering therapies (Statins/PCSK9 inhibitors), hypertension management, and the role of genetics in cardiovascular risk. This ranking serves as a definitive strategic resource for cardiologists, clinical researchers, and healthcare administrators. It offers a clear perspective on which academic contributions have successfully transitioned from benchtop discovery to the bedside, forming the bedrock of modern cardiovascular care in the 21st century.